These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33217807)

  • 1. Comorbid irritable bowel syndrome symptoms and headache have greater association with anxiety than depression: Annual health check-up survey results.
    Kawashima K; Fukuba N; Uemura Y; Ota K; Kazumori H; Sonoyama H; Oka A; Tada Y; Mishima Y; Oshima N; Yuki T; Katsube T; Kinoshita Y; Ishihara S
    Medicine (Baltimore); 2020 Nov; 99(47):e23059. PubMed ID: 33217807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
    Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
    Funaki Y; Kaneko H; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anxiety and depression on the risk of irritable bowel syndrome in migraine patients.
    Wu MF; Yang YW; Chen YY
    J Clin Neurosci; 2017 Oct; 44():342-345. PubMed ID: 28694040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
    Van Oudenhove L; Törnblom H; Störsrud S; Tack J; Simrén M
    Gastroenterology; 2016 Apr; 150(4):866-74. PubMed ID: 26602216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression.
    Kamp KJ; Levy RL; Munson SA; Heitkemper MM
    J Clin Gastroenterol; 2022 Feb; 56(2):e149-e152. PubMed ID: 33780216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
    Zamani M; Alizadeh-Tabari S; Zamani V
    Aliment Pharmacol Ther; 2019 Jul; 50(2):132-143. PubMed ID: 31157418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.
    Remes-Troche JM; Torres-Aguilera M; Montes-Martínez V; Jiménez-García VA; Roesch-Dietlen F
    Neurogastroenterol Motil; 2015 Jun; 27(6):824-31. PubMed ID: 25817438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and impact of irritable bowel syndrome in people with epilepsy.
    Camara-Lemarroy CR; Escobedo-Zúñiga N; Ortiz-Zacarias D; Peña-Avendaño J; Villarreal-Garza E; Díaz-Torres MA
    Epilepsy Behav; 2016 Oct; 63():29-33. PubMed ID: 27552483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth.
    Bengtson MB; Aamodt G; Vatn MH; Harris JR
    BMC Gastroenterol; 2015 Feb; 15():9. PubMed ID: 25649866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the burden of irritable bowel syndrome among university students in Saudi Arabia: A study on prevalence, psychological associations, and well-being.
    Alshaikh AA; Alamri SM; Riaz F; Mahmood SE; Shlwan MAM; Naser A Almuidh F; Alshahrani OAS; Asiri MAM; Almuaddi ASH; Al Qasim NYY; AlJebreel MAM; Ghazy RM
    Medicine (Baltimore); 2024 May; 103(19):e38099. PubMed ID: 38728477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.
    Thakur ER; Quigley BM; El-Serag HB; Gudleski GD; Lackner JM
    J Psychosom Res; 2016 Sep; 88():48-53. PubMed ID: 27521653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans.
    Harding K; Simpson T; Kearney DJ
    J Altern Complement Med; 2018 Dec; 24(12):1159-1165. PubMed ID: 30160516
    [No Abstract]   [Full Text] [Related]  

  • 17. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Psychology and Extragastrointestinal Symptoms on Health Care Use by Subjects With and Without Irritable Bowel Syndrome.
    McNaughton DT; Andreasson A; Ljótsson B; Beath AP; Hush JM; Talley NJ; Ljunggren G; Schmidt PT; Agréus L; Jones MP
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):847-854.e1. PubMed ID: 31323378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.
    Midenfjord I; Polster A; Sjövall H; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2019 Aug; 31(8):e13619. PubMed ID: 31056802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
    Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
    BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.